Summary
33 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 21 USD is left as free cash.
- The price moves less than the market (beta 0.07).
What to watch
- Revenue fell by 41% a year over the last 3 years.
- The company made a loss over the last 12 months.
- It passes only 2 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
Revenue fell by 41% a year over the last 3 years.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2022By product
- Product 99%
- Service 1.2%
By region
The company reports no revenue by region.
Product brings in 99% of revenue. Service grew fastest, by 25% a year.
Segments in detail